查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999072

神经外科医疗设备市场：依产品类型、手术方法、最终用户和应用划分－2026-2032年全球市场预测

Neurosurgery Devices Market by Product Type, Procedure, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，神经外科医疗设备市场价值将达到 149.1 亿美元，到 2026 年将成长至 169.2 亿美元，到 2032 年将达到 376.4 亿美元，复合年增长率为 14.13%。

主要市场统计数据
基准年 2025 149.1亿美元
预计年份：2026年 169.2亿美元
预测年份：2032年 376.4亿美元
复合年增长率 (%) 14.13%

对神经外科医疗设备进行全面概述，重点在于技术融合、临床应用压力、监管变化及其对策略决策的影响。

随着技术创新与医疗服务模式的变革以及临床期望的不断提高相融合，神经外科医疗设备的研发正在加速发展。该领域如今涵盖了从生物活性植入材料和先进植入系统到高清内视镜和导航平台等众多方面，这些设备能够实现精准手术。同时，临床实践正朝着微创方向发展，医疗系统在实施相关技术之前，需要获得充分的安全性、有效性和经济价值的证据。这些趋势正在重塑采购政策、临床工作流程以及製造商和供应商的竞争格局。

分析技术创新、临床实务变革、监管加强和商业性结构调整如何重塑神经外科医疗设备的开发和部署。

神经外科医疗设备领域正经历一系列变革，涵盖技术、临床、监管和商业性等多个面向。在技​​术层面，成像、电磁和光学导航以及微型内视镜的进步，使外科医生能够更精准地进行手术，并减少对周围组织的损伤。除了这些改进之外，旨在改善骨癒合和神经组织相容性的植入材料和生物假体的进步，也正在提升患者的长期疗效。机器人辅助和人工智慧驱动的影像引导技术正从实验阶段走向实用化，从而降低复杂手术的差异性，并缩短训练週期。

评估关税引起的成本压力和供应链调整如何改变了神经外科医疗设备製造商的筹资策略、产品设计选择和商业化时间表。

2025年实施的新关税措施引发了整个神经外科医疗设备生态系统的一系列营运和策略性应变措施。依赖国际供应链的製造商面临零组件和成品采购成本上升的困境，这给其利润率结构和定价策略带来了压力。为此，许多企业采取了短期战术措施，以降低对单一国家供应的依赖风险，例如重新调整生产批次的优先顺序、增加关键零件的库存缓衝以及加快双战术性认证。从稍长远的观点来看，关税环境正在促使企业重新评估製造地的地理位置，从而更加重视将生产迁回国内以及多元化发展至其他成本更低的製造地区。

以细分主导的临床和商业情报，将产品子类别、最终用户环境、应用和治疗类型联繫起来，优先考虑创新和市场进入方案。

细分市场分析揭示了不同产品类别、终端用户、临床应用和治疗方法中存在的细微机会和营运需求。产品类型细分包括生物製剂、内视镜、植入式设备、仪器、导航系统和神经刺激设备。在生物製剂领域，骨移植和生长因子日益受到关注，凸显了对能够与宿主组织整合并降低再次手术风险的材料的需求。这促使研发人员优先考虑生物活性、灭菌相容性和供应链可追溯性。内视镜分为软式内视镜内视镜和硬式内视镜，二者的应用模式各不相同。软式内视镜在弯曲的解剖结构和门诊手术中应用越来越广泛，而硬式内视镜由于其影像稳定性，在某些颅内和脊椎手术中仍然是首选。植入式医疗器材可细分为颅脑植入物和脊椎移植，其中颅脑植入又包括颅骨板和硬脑膜替代物，脊椎移植则包括融合器和椎弓骨钉。本文的研究结果强调了植入的生物相容性、模组化和易于固定对于缩短手术时间和降低併发症发生率的重要性。临床团队正在评估包括钻头、穿孔器、牵开器系统和超音波吸引器在内的各种手术器械的人体工学设计、消毒流程以及与微创手术的兼容性。导航系统分为电磁平台和光学平台，需要精确定位并与成像系统互通性。神经刺激设备分为深部脑部刺激器和迷走神经刺激设备，其发展得益于导线技术的改进和封闭回路型编程选项的增加，从而支持更广泛的治疗适应症。

对临床基础设施、监管细微差别、采购趋势和策略方法进行区域比较评估，以加快在全球主要地区的部署。

区域趋势正在影响商业机会和产业计画，美洲、欧洲、中东和非洲以及亚太地区的优先事项各不相同。在美洲，一体化医疗保健系统和先进的门诊手术中心网路正在催生对能够在各种医疗保健环境中展现出明确经济和临床价值的医疗设备的需求。该地区的监管流程日益符合上市后证据的要求，要求製造商投资于註册登记和结果追踪。欧洲、中东和非洲的市场环境各不相同，在报销机制、医院采购实务和临床基础设施方面存在显着的区域差异。希望在市场站稳脚跟的製造商必须根据各国的医疗技术评估流程调整打入市场策略，并与当地临床领导者合作克服推广障碍。在亚太地区，医院基础设施的快速扩张、神经外科手术的增加以及政府主导的医疗保健系统投资正在推动对高度可扩展的医疗设备解决方案和本地製造伙伴关係关係的需求。在所有地区，供应链韧性、协调法规的努力以及数位整合能力都是影响采购决策和长期伙伴关係的差异化因素。

本书探讨了整合平台、专业创新者和契约製造方案如何影响产品开发和业务扩张，并研究了企业策略行动和伙伴关係模式。

从公司层面来看，趋势揭示了一个竞争格局：成熟的医疗技术公司、专注于特定设备的专业公司以及创新Start-Ups，都在塑造神经外科医学的未来方面发挥着各自独特的作用。主要企业正投资于平台策略，整合硬体、软体和资讯服务，建立整合解决方案，以减少临床差异并实现可衡量的疗效。同时，专注于特定领域的专业公司和新兴企业正在推动“点创新”，例如突破性的生技药品、精密的植入设计或新一代刺激导线，这些创新旨在解决特定的临床难题，并使它们成为极具吸引力的合作和收购目标。

实用、跨产业的指导，用于产品开发、供应链弹性、证据产生和商业化，以确保永续采用和竞争优势。

产业领导企业应采取优先排序的跨部门方法，将产品创新与实证实践、供应链韧性和以客户为中心的商业化相结合。首先，在研发週期的早期阶段就应整合临床证据规划，确保临床试验、註册登记和真实世界资料收集能够满足外科医生、保险公司和采购者的关键需求。这种前瞻性的方法可以缩短商业化时间，并增强医保报销的竞争力。其次，应重新设计供应链策略，减少对单一供应商的依赖，并在关税风险和物流中断可能显着影响手术时间的地区探索本地生产和双重采购模式。投资于供应商合格和材料工程可以带来可持续的成本和品质优势。

采用透明的混合方法研究途径，结合对从业人员的访谈、临床文献、监管审查和情境分析，得出可靠的结论。

本摘要总结的研究结果是基于一种混合研究方法，该方法结合了定性专家访谈、针对临床医生和采购经理的定向一手调查，以及对临床文献和监管文件的严谨二手研究。一手数据包括对神经外科医生、手术室管理人员、医院采购负责人、医疗设备工程师和卫生经济学专家的结构化访谈，旨在了解临床优先事项和采购趋势。这些观点与同行评审的临床研究、医疗设备註册资讯和公开的监管文件进行交叉比对，以检验临床性能声明、安全性概况和上市后义务。

整合策略挑战和风险因素，以决定哪些组织能够成功推动神经外科护理的临床应用和商业性规模化。

神经外科医疗设备生态系统正处于转折点，技术、临床需求、监管预期和地缘政治因素相互交织，迫使投资和实施重点进行重组。能够将差异化医疗设备能力与严谨的证据产生、稳健的供应链以及针对特定临床和区域环境量身定制的商业化策略相结合的企业，将拥有广阔的发展机会。反之，未能应对关税驱动的成本波动、日益严格的监管以及对可验证疗效日益增长的需求的企业，则可能面临产品推广延迟和商业性回报减少的风险。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：神经外科医疗设备市场：依产品类型划分

  • 生技药品
    • 骨移植材料
    • 生长因子
  • 内视镜
    • 柔性内视镜
    • 硬式内视镜
  • 植入式医疗设备
    • 颅骨植入
      • 颅骨板
      • 杜拉尔替代材料
    • 脊椎移植
      • 固定笼
      • 椎弓骨钉
  • 装置
    • 钻头和穿孔器
    • 牵开器系统
    • 超音波吸引器
  • 导航系统
    • 电磁系统
    • 光学系统
  • 神经刺激设备
    • 深部脑部刺激器
    • 迷走神经刺激设备

第九章：神经外科医疗设备市场：依手术方法划分

  • 内视镜手术
  • 雷射治疗
  • 微创手术
  • 开放性手术

第十章：神经外科医疗设备市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 研究机构
  • 专科诊所

第十一章 神经外科医疗设备市场：依应用领域划分

  • 脑肿瘤
  • 癫痫
  • 水脑症
  • 运动障碍
  • 疼痛管理
  • 脊髓疾病

第十二章 神经外科医疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 神经外科医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 神经外科医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国神经外科医疗设备市场

第十六章：中国神经外科医疗设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Penumbra, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-E370886767D8

The Neurosurgery Devices Market was valued at USD 14.91 billion in 2025 and is projected to grow to USD 16.92 billion in 2026, with a CAGR of 14.13%, reaching USD 37.64 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.91 billion
Estimated Year [2026] USD 16.92 billion
Forecast Year [2032] USD 37.64 billion
CAGR (%) 14.13%

Comprehensive orientation to neurosurgery devices highlighting technological convergence, clinical adoption pressures, regulatory evolution and implications for strategic decision-making

Neurosurgery device development is advancing at an accelerated pace as technological innovation converges with changing care delivery models and heightened clinical expectations. The field now spans a spectrum from biologically active graft materials and sophisticated implantable systems to high-definition endoscopes and navigation platforms that enable precision procedures. Concurrently, clinical practice is shifting toward less invasive approaches, and health systems are demanding robust evidence of safety, efficacy, and economic value before adoption. These dynamics are reshaping procurement preferences, clinical workflows, and competitive positioning for manufacturers and suppliers.

In parallel, regulatory frameworks and payer expectations are emphasizing real-world outcomes and post-market surveillance, which increases the importance of integrated data capture and longitudinal clinical studies. Investors are responding by favoring companies that demonstrate not only technical differentiation but also reproducible clinical benefits and credible commercialization pathways. As a result, product roadmaps are being designed with modularity and interoperability in mind, anticipating integration with navigation systems, neurostimulation platforms, and digital clinical decision support.

This introduction sets the stage for an analysis that interlinks clinical trends, device innovation, end-user behavior, and broader geopolitical and regulatory shifts. The following sections examine transformative changes in the landscape, tariff-driven operational impacts, segmentation-specific insights, regional dynamics, competitive behaviors, actionable recommendations, research methodology, and concluding implications for leaders shaping the future of neurosurgical care.

Analysis of converging technological innovations, clinical practice shifts, regulatory tightening, and commercial realignments reshaping neurosurgery device development and adoption

The neurosurgery device landscape is undergoing a set of transformative shifts that are simultaneously technological, clinical, regulatory, and commercial. On the technological front, advances in imaging, electromagnetic and optical navigation, and miniaturized endoscopy are enabling surgeons to operate with greater precision and reduced collateral tissue damage. These improvements are complemented by refinements in implant materials and biologic adjuncts designed to enhance bone healing and neural tissue compatibility, thereby improving long-term patient outcomes. Robotic assistance and AI-enabled image guidance are moving from experimental to pragmatic tools that reduce variability and shorten learning curves for complex procedures.

Clinically, the movement toward minimally invasive techniques and outpatient settings is changing procedural mixes and driving demand for instruments and devices that support shorter procedure times and rapid recovery. Neurostimulation technologies, particularly deep brain and vagus nerve stimulation, are expanding indications and seeing renewed interest as understanding of neuromodulation mechanisms deepens. Simultaneously, an increased emphasis on patient-reported outcomes and quality metrics is raising the bar for clinical evidence required to support adoption and reimbursement.

Regulatory and reimbursement landscapes are also shifting, with agencies requiring more comprehensive post-market data and payers looking for demonstrable value in terms of reduced complications, shorter hospital stays, and improved functional outcomes. On the commercial side, partnerships between established medtech firms, specialty device innovators, and clinical research networks are accelerating product translation while changing competitive dynamics. Taken together, these shifts create both opportunities and elevated execution risk for companies that must align product innovation with clinical utility and regulatory rigor.

Evaluation of how tariff-driven cost pressures and supply chain adjustments have reshaped sourcing strategies, product design choices, and commercialization timelines across neurosurgical device makers

The implementation of new tariff measures in the United States during 2025 has prompted a cumulative set of operational and strategic responses across the neurosurgery devices ecosystem. Manufacturers that rely on international supply chains have confronted increased landed costs for components and finished goods, which in turn pressures margin structures and pricing strategies. In response, many organizations initiated near-term tactical measures such as reprioritizing production runs, increasing inventory buffers for critical components, and accelerating dual-source qualification to reduce exposure to single-country supply dependencies. Over a slightly longer horizon, the tariff environment has encouraged a reevaluation of geographic manufacturing footprints, with increased consideration of reshoring or diversification into alternative low-cost manufacturing regions.

Beyond direct cost effects, tariffs have affected partner selection, contract negotiation, and capital allocation decisions. Procurement teams are renegotiating supplier agreements to incorporate tariff pass-through clauses and to obtain more favorable lead times and quality guarantees. Strategic teams are revisiting product designs to simplify bill-of-materials complexity, reduce reliance on tariff-sensitive components, and explore material substitutions that maintain clinical performance while mitigating cost risk. Clinical and regulatory teams are also involved, since design changes can trigger additional validation work and regulatory submissions, thereby affecting time-to-market.

Moreover, the tariff-induced dynamics have had downstream effects on clinical adoption timelines and health system purchasing behavior, as providers factor in potential supply volatility and total cost of ownership when evaluating new devices. Investors and corporate development groups are likewise recalibrating valuation models and partnership timelines to reflect the heightened operational uncertainty. Overall, the cumulative impact of the tariff changes has accelerated supply chain modernization efforts and heightened the importance of resilient, compliant, and clinically focused commercialization strategies.

Segmentation-driven clinical and commercial intelligence linking product subcategories, end-user settings, applications, and procedure types to prioritize innovation and market entry choices

Segmentation analysis reveals nuanced opportunities and execution imperatives across product classes, end users, clinical applications, and procedural approaches. Product type segmentation spans biologics, endoscopes, implantable devices, instruments, navigation systems, and neurostimulators. Within biologics, the focus on bone grafts and growth factors highlights a demand for materials that integrate with host tissue and reduce revision risk, prompting developers to prioritize bioactivity, sterilization compatibility, and supply chain traceability. Endoscopes, differentiated into flexible and rigid designs, show distinct adoption patterns: flexible endoscopes are gaining traction in tortuous anatomy and outpatient procedures, while rigid endoscopes continue to be preferred for certain intracranial and spinal exposures due to image stability. Implantable devices subdivide into cranial and spinal implants, with cranial implants further segmented into cranial plates and dural substitutes and spinal implants emphasizing fusion cages and pedicle screws; insights here underscore the premium on implant biocompatibility, modularity, and ease of fixation to reduce operative time and complication rates. Instruments, encompassing drills and perforators, retractor systems, and ultrasonic aspirators, are being evaluated by clinical teams for ergonomics, sterilization cycles, and compatibility with minimally invasive access. Navigation systems, split between electromagnetic and optical platforms, must deliver registration accuracy and interoperability with imaging suites. Neurostimulators, categorized into deep brain stimulators and vagus nerve stimulators, are advancing through refined lead technologies and closed-loop programming options that support expanded therapeutic indications.

End user segmentation includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. Ambulatory surgical centers are driving demand for compact, cost-effective devices that enable same-day discharge, whereas hospitals prioritize systems that integrate with existing imaging and monitoring infrastructure and support complex case mixes. Research institutes and specialty clinics serve as early adopters, providing clinical evidence and proof-of-concept data that can accelerate broader adoption.

Application segmentation covers brain tumors, epilepsy, hydrocephalus, movement disorders, pain management, and spinal cord disorders. Each application imposes distinct clinical performance requirements, ranging from precision resection margins for oncologic procedures to long-term stimulation durability for movement and pain indications. Procedure segmentation encompasses endoscopic surgery, laser therapy, minimally invasive surgery, and open surgery, and these procedural contexts determine device form factors, sterilization regimens, and instrument sets. Synthesizing these segmentation lenses highlights where clinical unmet needs intersect with technological capability and where targeted evidence generation and commercialization investments will deliver highest impact.

Comparative regional assessment of clinical infrastructure, regulatory nuance, procurement behavior, and strategic pathways to accelerate adoption across major global territories

Regional dynamics are shaping both opportunity and operational planning, with distinct priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, consolidated health systems and progressive ambulatory surgical center networks are creating demand for devices that demonstrate clear economic and clinical value across diverse care settings. Regulatory pathways in the region are increasingly aligned with post-market evidence expectations, requiring manufacturers to invest in registries and outcomes tracking. The Europe, Middle East & Africa region presents a heterogeneous landscape where reimbursement mechanisms, hospital procurement practices, and clinical infrastructure vary widely; manufacturers seeking traction must tailor market access strategies to national health technology assessment processes and engage local clinical champions to navigate adoption barriers. In the Asia-Pacific region, rapid hospital infrastructure expansion, growing neurosurgical caseloads, and government-led investment in healthcare capacity are driving demand for scalable device solutions and localized manufacturing partnerships. Across all regions, supply chain resilience, regulatory harmonization efforts, and digital integration capabilities are differentiators that influence both purchasing decisions and long-term partnerships.

Transnational considerations further complicate regional strategies. Cross-border clinical trials, regulatory equivalence initiatives, and multiregional reimbursement pilots can accelerate global launches but require careful orchestration of regulatory filings, clinical evidence packages, and training programs. Manufacturers that design regional rollouts to leverage center-of-excellence partnerships, digital training platforms, and adaptive pricing structures are better positioned to translate early clinical uptake into sustained adoption and favorable procurement terms.

Strategic company behaviors and partnership models revealing how integrated platforms, specialty innovators, and contract manufacturing choices influence commercialization and scaling

Company-level behaviors reveal a competitive landscape where established medtech firms, focused device specialists, and innovative startups each play distinct roles in shaping the trajectory of neurosurgical care. Leading firms are investing in platform strategies that bundle hardware, software, and data services to create integrated solutions that lower clinical variability and provide measurable outcomes. At the same time, focused specialists and emerging companies are advancing point innovations-novel biologics, refined implant designs, or next-generation stimulation leads-that address specific clinical gaps and can be attractive targets for partnership or acquisition.

Across the ecosystem, commercialization strategies emphasize evidence generation, clinician training, and service models that support device uptime and clinical outcomes. Strategic partnerships between device manufacturers, imaging and navigation vendors, and academic centers are accelerating product validation and clinician endorsement. Manufacturing partners and contract service providers are also central to scalability, particularly for companies that elect to regionalize production to mitigate tariff and logistics risks. Additionally, firms that prioritize transparent pricing, robust post-market surveillance, and clear interoperability standards are finding smoother pathways into health system procurement processes. In aggregate, company insights point to a bifurcated market where platform incumbents focus on integrated solutions and specialty innovators pursue clinical differentiation, both needing disciplined execution across regulatory, clinical, and commercial dimensions.

Actionable cross-functional guidance for product development, supply resilience, evidence generation, and commercialization to secure durable adoption and competitive advantage

Industry leaders should take a prioritized, cross-functional approach that aligns product innovation with evidence generation, supply resilience, and customer-centric commercialization. First, embed clinical evidence planning early in development cycles so that trials, registries, and real-world data capture address the endpoints that matter to surgeons, payers, and purchasers. This anticipatory approach shortens commercialization timelines and enhances reimbursement positioning. Next, redesign supply chain strategies to reduce single-source exposure and to evaluate regional manufacturing or dual-sourcing where tariff risk or logistics disruption could materially affect time-to-surgery. Investing in supplier qualification and materials engineering can yield durable cost and quality advantages.

Commercially, tailor value propositions to specific end-user segments: ambulatory surgical centers seek compact, cost-effective solutions; hospitals demand interoperability and service reliability; specialty clinics value clinical performance and training. Develop modular platforms and compatible instrument ecosystems to reduce procurement friction and to enable incremental upgrades rather than wholesale replacements. Operationally, expand clinician training programs through digital simulation and proctoring models to accelerate surgeon proficiency and to capture early outcome data. Regulatory and quality teams should prepare for iterative submissions by documenting post-market surveillance plans and by building electronic data capture processes that support compliance with regional requirements.

Finally, pursue alliances that complement internal capabilities, whether for advanced navigation, biologic manufacturing, or clinical research networks. Prioritize commercial pilots with high-impact centers that can produce reproducible outcomes and serve as reference accounts. By executing on these recommendations, leaders can improve the odds of durable adoption and create defensible competitive positioning in a dynamic neurosurgical device landscape.

Transparent mixed-methods research approach integrating practitioner interviews, clinical literature, regulatory review, and scenario analysis to underpin robust conclusions

The findings synthesized in this summary are grounded in a mixed-methods research approach that combined qualitative expert interviews, targeted primary research with clinicians and purchasing leaders, and rigorous secondary analysis of clinical literature and regulatory documentation. Primary inputs included structured interviews with neurosurgeons, operating room managers, hospital procurement specialists, device engineers, and health economics experts to capture both clinical priorities and procurement dynamics. These perspectives were triangulated with peer-reviewed clinical studies, device registries, and public regulatory filings to validate clinical performance claims, safety profiles, and post-market obligations.

Analytical methods included thematic synthesis to identify principal clinical and commercial trends, scenario analysis to evaluate the operational impacts of tariff changes and supply chain disruptions, and segmentation mapping to align device attributes with end-user needs and procedural contexts. Quality assurance protocols ensured that all claims were corroborated by more than one source and that conflicting inputs were reconciled through follow-up interviews or sensitivity checks. Ethical and compliance considerations governed the handling of primary data, and anonymized summaries of interview findings were used to protect confidentiality while preserving the richness of practitioner insight.

This methodological framework supports robust, actionable conclusions by integrating practitioner insight with documentary evidence and by explicitly addressing areas of uncertainty through scenario planning and sensitivity assessment.

Synthesis of strategic imperatives and risk considerations that will determine which organizations succeed in advancing clinical adoption and commercial scale in neurosurgical care

The neurosurgery devices ecosystem sits at an inflection point where technology, clinical demand, regulatory expectations, and geopolitical factors converge to reshape investment and execution priorities. Opportunities are abundant for organizations that can align differentiated device capabilities with rigorous evidence generation, resilient supply chains, and tailored commercialization strategies for specific clinical and regional contexts. Conversely, companies that fail to plan for tariff-induced cost volatility, regulatory rigor, and the increasing demand for demonstrable outcomes risk slower adoption and eroded commercial returns.

Leaders should focus on building interoperable platforms, investing in clinician training and real-world evidence programs, and structuring supply chains to minimize disruption risk. Strategic partnerships and targeted M&A can accelerate access to complementary technologies and clinical channels, while prudent product design choices can reduce total cost of ownership for providers. Ultimately, success in this market will favor organizations that take a systems-thinking approach, integrating engineering excellence with clinical validation and adaptive commercialization models that reflect the realities of care delivery across regions and provider types.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurosurgery Devices Market, by Product Type

  • 8.1. Biologics
    • 8.1.1. Bone Grafts
    • 8.1.2. Growth Factors
  • 8.2. Endoscopes
    • 8.2.1. Flexible Endoscopes
    • 8.2.2. Rigid Endoscopes
  • 8.3. Implantable Devices
    • 8.3.1. Cranial Implants
      • 8.3.1.1. Cranial Plates
      • 8.3.1.2. Dural Substitutes
    • 8.3.2. Spinal Implants
      • 8.3.2.1. Fusion Cages
      • 8.3.2.2. Pedicle Screws
  • 8.4. Instruments
    • 8.4.1. Drills And Perforators
    • 8.4.2. Retractor Systems
    • 8.4.3. Ultrasonic Aspirators
  • 8.5. Navigation Systems
    • 8.5.1. Electromagnetic Systems
    • 8.5.2. Optical Systems
  • 8.6. Neurostimulators
    • 8.6.1. Deep Brain Stimulators
    • 8.6.2. Vagus Nerve Stimulators

9. Neurosurgery Devices Market, by Procedure

  • 9.1. Endoscopic Surgery
  • 9.2. Laser Therapy
  • 9.3. Minimally Invasive Surgery
  • 9.4. Open Surgery

10. Neurosurgery Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Research Institutes
  • 10.4. Specialty Clinics

11. Neurosurgery Devices Market, by Application

  • 11.1. Brain Tumors
  • 11.2. Epilepsy
  • 11.3. Hydrocephalus
  • 11.4. Movement Disorders
  • 11.5. Pain Management
  • 11.6. Spinal Cord Disorders

12. Neurosurgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurosurgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurosurgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Neurosurgery Devices Market

16. China Neurosurgery Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. B. Braun Melsungen AG
  • 17.7. Boston Scientific Corporation
  • 17.8. Globus Medical, Inc.
  • 17.9. Integra LifeSciences Holdings Corporation
  • 17.10. Johnson & Johnson
  • 17.11. Medtronic plc
  • 17.12. Penumbra, Inc.
  • 17.13. Smith & Nephew plc
  • 17.14. Stryker Corporation
  • 17.15. Terumo Corporation
  • 17.16. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROSURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROSURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. GCC NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. GCC NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 248. GCC NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 251. GCC NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. GCC NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 254. GCC NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. GCC NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. G7 NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. G7 NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 286. G7 NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 287. G7 NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 288. G7 NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 290. G7 NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 291. G7 NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 292. G7 NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 294. G7 NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. G7 NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. NATO NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. NATO NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 299. NATO NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 300. NATO NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 301. NATO NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 302. NATO NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 305. NATO NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 306. NATO NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 307. NATO NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. NATO NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY CR